The Wall Street Journal said on Monday that the U.S. health agency had approved billionaire Elon Musk’s Neuralink to implant its brain chip in a second person after the company offered to address an issue that came up with its first patient.
Neuralink said earlier this month that its first patient’s small wire implants had come loose. As revealed last week, the business was aware that the wires might retract based on testing on animals. According to a document the WSJ saw and a source familiar with the company, the company plans to address the issue by implanting part of the device’s cables deeper into the brain.
More than 1,000 quadriplegics have registered for Neuralink’s patient registry, and the company aims to implant its device in a second patient in June and ten people overall this year, according to the report.
According to the source, the company also plans to apply for similar trials to start in the coming months to regulators in Britain and Canada.
According to the FDA, it is not permitted to talk about or reveal details about any specific company’s application for or study involving human trials.
According to them, the first patient to have the brain chip implanted was able to use their thoughts to manipulate a computer mouse in February with “no ill effects.”
According to Neuralink, the study makes use of a robot to surgically implant a brain-computer interface device in a part of the brain that regulates the intention to move.